GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILLF) » Definitions » EV-to-FCF

WILLF (Demant AS) EV-to-FCF : 21.21 (As of Mar. 24, 2025)


View and export this data going back to . Start your Free Trial

What is Demant AS EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Demant AS's Enterprise Value is $9,920 Mil. Demant AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $468 Mil. Therefore, Demant AS's EV-to-FCF for today is 21.21.

The historical rank and industry rank for Demant AS's EV-to-FCF or its related term are showing as below:

WILLF' s EV-to-FCF Range Over the Past 10 Years
Min: 18.12   Med: 37.56   Max: 60.45
Current: 20.52

During the past 13 years, the highest EV-to-FCF of Demant AS was 60.45. The lowest was 18.12. And the median was 37.56.

WILLF's EV-to-FCF is ranked better than
60.47% of 382 companies
in the Medical Devices & Instruments industry
Industry Median: 27.355 vs WILLF: 20.52

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-24), Demant AS's stock price is $37.5495. Demant AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $1.564. Therefore, Demant AS's PE Ratio (TTM) for today is 24.01.


Demant AS EV-to-FCF Historical Data

The historical data trend for Demant AS's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS EV-to-FCF Chart

Demant AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.92 30.45 33.52 21.72 21.49

Demant AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.52 - 21.72 - 21.49

Competitive Comparison of Demant AS's EV-to-FCF

For the Medical Devices subindustry, Demant AS's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Demant AS's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Demant AS's EV-to-FCF falls into.



Demant AS EV-to-FCF Calculation

Demant AS's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9919.897/467.739
=21.21

Demant AS's current Enterprise Value is $9,920 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $468 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Demant AS  (OTCPK:WILLF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Demant AS's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=37.5495/1.564
=24.01

Demant AS's share price for today is $37.5495.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Demant AS's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $1.564.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Demant AS EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Demant AS's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Demant AS Business Description

Address
Kongebakken 9, Smorum, DNK, 2765
Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.

Demant AS Headlines